California, Hawaii, Oregon and Washington issued COVID-19, influenza, and RSV vaccination guidance in line with former CDC recommendations.

ACIP voted unanimously to recommend that adults aged more than 65 years discuss with an HCP before receiving the COVID-19 vaccines.

Upadacitinib and secukinumab for PsA offers comparable improvements in skin and joint symptoms, but adalimumab offers superior pain relief.

Patients with psoriasis had a significantly increased risk for developing unspecified age-related macular degeneration at 10 years.

A digital psychological intervention was linked to improved psychological outcomes and quality of life in patients with IRDs.

The FDA has expanded the approval of Opzelura to include patients 2 to 11 years of age for treatment of mild to moderate atopic dermatitis.

Topical ruxolitinib does not carry the same safety profile as oral JAK inhibitors for AD, which may warrant reconsideration of the boxed warning.

DermaRite Industries widened its recall of personal care products contaminated with Burkholderia cepacia complex.

The ACIP voted to recommend that the combined MMRV vaccine not be given before age 4 years and will vote on the hepatitis B vaccine Friday.

Officials from the Centers for Medicare and Medicaid Services moved to close Miami’s Life Alliance Organ Recovery Agency over safety issues.

The FDA has approved updated labeling for Vyjuvek (beremagene geperpavec-svdt), a topical gene therapy for dystrophic epidermolysis bullosa.

Skin cancer risk was significantly reduced with nicotinamide initiation and more so with initiation after a first skin cancer.